4.6 Review

Wild-type and mutant p53 in cancer-related ferroptosis. A matter of stress management?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Drugging p53 in cancer: one protein, many targets

Ori Hassin et al.

Summary: Mutations in the TP53 gene are common in cancer, but restoring p53 functionality has been considered impossible for a long time. However, recent years have seen promising developments in p53-based therapy, including improved strategies and novel approaches. Small molecules that protect or restore p53 function are gaining interest, along with tailored drugs for specific p53 mutants. Additionally, gene therapy and immunotherapy are being reconsidered. However, significant challenges remain.

NATURE REVIEWS DRUG DISCOVERY (2023)

Review Biochemistry & Molecular Biology

p53 in ferroptosis regulation: the new weapon for the old guardian

Yanqing Liu et al.

Summary: p53 plays a crucial role in tumor suppression through modulating ferroptosis, a form of iron-dependent non-apoptotic cell death. Through its metabolic targets, p53 can regulate the cellular response to ferroptosis inducers. This review also discusses the potential of targeting p53-mediated ferroptotic responses for the treatment of human cancers and other diseases.

CELL DEATH AND DIFFERENTIATION (2022)

Article Hematology

APR-246 induces early cell death by ferroptosis in acute myeloid leukemia

Rudy Birsen et al.

Summary: APR 246 is a promising therapeutic agent for myelodysplastic syndromes and acute myeloid leukemia that targets p53 mutated proteins. It has been found to reactivate the transcriptional activity of p53 mutants and induce p53-independent cell death. The study also demonstrates the association between APR 246 and ferroptosis, a recently described cell death process. The detoxification capacity of AML cells to maintain glutathione biosynthesis may play a key role in determining sensitivity to APR 246.

HAEMATOLOGICA (2022)

Article Oncology

The complexity of p53-mediated metabolic regulation in tumor suppression

Yanqing Liu et al.

Summary: The metabolic regulation of p53 in tumor suppression is complex and diverse. It inhibits tumor development through regulating glucose, lipid, amino acid, nucleotide, iron metabolism, and ROS production.

SEMINARS IN CANCER BIOLOGY (2022)

Review Biochemistry & Molecular Biology

Should mutant TP53 be targeted for cancer therapy?

Zilu Wang et al.

Summary: Mutations in the TP53 gene are common in human cancers and can lead to tumor development. Mutant TP53 proteins often have high expression levels in malignant cells and can impair the response of these cells to anti-cancer drugs. These mutant proteins have been found to affect cellular pathways through loss-of-function, dominant negative effects, and gain-of-function mechanisms. The sustained proliferation and survival of malignant cells rely on the gain-of-function effects of mutant TP53 proteins, suggesting that targeting these proteins could have therapeutic potential.

CELL DEATH AND DIFFERENTIATION (2022)

Article Biochemistry & Molecular Biology

Mutant p53: it's not all one and the same

Margaret C. Kennedy et al.

Summary: Mutation of the TP53 tumor suppressor gene is common in cancer, with different alleles affecting cancer in various ways. Research is focusing on understanding how TP53 mutations impact cancer and developing new therapeutic approaches based on this understanding. Studies are also exploring whether tumors with distinct TP53 mutations have unique characteristics.

CELL DEATH AND DIFFERENTIATION (2022)

Article Oncology

APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations

Yuheng Hong et al.

Summary: TP53 mutations are associated with poor prognosis in DLBCL, particularly in GCB and UNC subtypes. APR-246 shows anti-tumor effects by restoring binding of mutant p53 to target genes. Mutations in exons 5, 6, and 7 of TP53 are predictors of progression and survival in DLBCL.

LEUKEMIA (2022)

Article Multidisciplinary Sciences

Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction

Kenji M. Fujihara et al.

Summary: Eprenetapopt acts as an anticancer agent by increasing cellular antioxidant glutathione turnover, leading to ferroptosis, a nonapoptotic form of cell death. It also inhibits iron-sulfur cluster biogenesis and synergizes with dietary serine and glycine restriction to inhibit tumor growth.

SCIENCE ADVANCES (2022)

Review Oncology

GOF Mutant p53 in Cancers: A Therapeutic Challenge

Lobsang Dolma et al.

Summary: In normal cells, p53 regulates cell cycle progression. However, in cancer, mutations in the p53 gene can cause the protein to lose its normal function and instead promote tumor growth and resistance to chemotherapy. This review discusses new strategies to target mutant p53-bearing cancers and reinstate sensitivity to chemotherapy.

CANCERS (2022)

Letter Cell Biology

Sirt3 is critical for p53-mediated ferroptosis upon ROS-induced stress

Ying Jin et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2021)

Review Cell Biology

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies

Jolanda Magri et al.

Summary: xCT, a tumor-associated antigen, plays a crucial role in protecting cancer cells from oxidative stress and ferroptosis by participating in glutathione biosynthesis. Overexpression of xCT in cancer stem cells and its regulation by TP53, both wild-type and mutant, are important research directions. Combining APR-246 treatment with anti-xCT immunotargeting shows promise in cancer therapy.
Review Oncology

Mutant p53 as a Regulator and Target of Autophagy

Yong Shi et al.

Summary: The article discusses the mutation of the TP53 gene in cancer and its regulatory role in autophagy, explores the potential role of mutant p53 proteins in different autophagic pathways, and discusses potential strategies for targeting mutant p53 in cancer treatment through autophagy.

FRONTIERS IN ONCOLOGY (2021)

Review Cell Biology

Mutant p53 in cell-cell interactions

Steven Pilley et al.

Summary: p53 is a crucial tumor suppressor gene, and mutations in p53 can impact cancer development and progression. In addition to its cell-autonomous functions, the status of p53 can also influence the interactions between cancer cells.

GENES & DEVELOPMENT (2021)

Article Multidisciplinary Sciences

DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer

Chao Mao et al.

Summary: The study reveals the mechanism of ferroptosis induced by inhibiting GPX4 in cancer cells, as well as the potential pathways to enhance or inhibit ferroptosis by intervening in relevant metabolic pathways. Therapeutic strategies targeting different levels of GPX4 expression could be a promising new approach for cancer treatment.

NATURE (2021)

Article Multidisciplinary Sciences

iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4

Delin Chen et al.

Summary: The study identifies iPLA2 beta as a critical regulator for p53-driven ferroptosis independent of GPX4. Loss of iPLA2 beta does not have obvious effect on normal cells, but it plays an essential role in regulating ferroptosis upon ROS-induced stress. iPLA2 beta is a promising therapeutic target for activating ferroptosis-mediated tumor suppression without serious toxicity concerns.

NATURE COMMUNICATIONS (2021)

Review Oncology

Endoplasmic reticulum stress signals in the tumour and its microenvironment

Xi Chen et al.

Summary: This review explores how ER stress in the tumor microenvironment can influence the functions of cancer cells and immune cells, leading to vulnerabilities that could be targeted by emerging therapeutic strategies. The tightly regulated processes of protein handling, modification, and folding in the ER determine cell function and survival, and disruptions in ER homeostasis can result in a state of persistent ER stress with pro-tumoral effects in cancer cells and immunomodulatory effects in immune cells.

NATURE REVIEWS CANCER (2021)

Article Biochemistry & Molecular Biology

Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis

Yilong Zou et al.

NATURE CHEMICAL BIOLOGY (2020)

Article Chemistry, Multidisciplinary

GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling

Vanessa A. N. Kraft et al.

ACS CENTRAL SCIENCE (2020)

Review Cell Biology

Ferroptosis: a new unexpected chance to treat metastatic melanoma?

Mara Gagliardi et al.

CELL CYCLE (2020)

Article Multidisciplinary Sciences

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

Valeria Capaci et al.

NATURE COMMUNICATIONS (2020)

Review Oncology

Ferroptosis in Cancer Treatment: Another Way to Rome

Yinan Wu et al.

FRONTIERS IN ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway

Juan Liu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

p53: 800 million years of evolution and 40 years of discovery

Arnold J. Levine

NATURE REVIEWS CANCER (2020)

Article Biochemistry & Molecular Biology

HIF-transcribed p53 chaperones HIF-1α

Esha Madan et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Multidisciplinary Sciences

FSP1 is a glutathione-independent ferroptosis suppressor

Sebastian Doll et al.

NATURE (2019)

Article Multidisciplinary Sciences

The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis

Kirill Bersuker et al.

NATURE (2019)

Article Cell Biology

Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis

Mara Gagliardi et al.

CELL DEATH & DISEASE (2019)

Review Biochemistry & Molecular Biology

Mutant p53 as a guardian of the cancer cell

Fiamma Mantovani et al.

CELL DEATH AND DIFFERENTIATION (2019)

Review Cell Biology

p53 as a hub in cellular redox regulation and therapeutic target in cancer

Sofi E. Eriksson et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2019)

Review Oncology

NRF2 and the Hallmarks of Cancer

Montserrat Rojo de la Vega et al.

CANCER CELL (2018)

Article Chemistry, Multidisciplinary

Resolving the Role of Lipoxygenases in the Initiation and Execution of Ferroptosis

Ron Shah et al.

ACS CENTRAL SCIENCE (2018)

Review Endocrinology & Metabolism

The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis

Keerthana Gnanapradeepan et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Editorial Material Cell Biology

Strategies for Modulating Oxidative Stress under Diverse Physiological and Pathological Conditions

Karolina Szewczyk-Golec et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)

Review Oncology

Complexes formed by mutant p53 and their roles in breast cancer

Arianna Bellazzo et al.

BREAST CANCER-TARGETS AND THERAPY (2018)

Review Biochemistry & Molecular Biology

p53-Mediated Molecular Control of Autophagy in Tumor Cells

Maria Mrakovcic et al.

BIOMOLECULES (2018)

Review Biochemistry & Molecular Biology

Mutant p53 partners in crime

Michael P. Kim et al.

CELL DEATH AND DIFFERENTIATION (2018)

Review Cell Biology

Oxidative Stress: Harms and Benefits for Human Health

Gabriele Pizzino et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Review Oncology

Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate

Marco Corazzari et al.

FRONTIERS IN ONCOLOGY (2017)

Review Biochemistry & Molecular Biology

Molecular interplay between mutant p53 proteins and autophagy in cancer cells

Marco Cordani et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)

Article Cell Biology

Autophagy promotes ferroptosis by degradation of ferritin

Wen Hou et al.

AUTOPHAGY (2016)

Article Multidisciplinary Sciences

Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5

Fotini Vogiatzi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Cell Biology

Ferrootosis: Death by Lipid Peroxidation

Wan Seok Yang et al.

TRENDS IN CELL BIOLOGY (2016)

Article Cell Biology

Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression

Shang-Jui Wang et al.

CELL REPORTS (2016)

Review Oncology

Adaptive Stress Responses During Tumor Metastasis and Dormancy

Daniela Senft et al.

TRENDS IN CANCER (2016)

Review Biochemistry & Molecular Biology

Autophagy in malignant transformation and cancer progression

Lorenzo Galluzzi et al.

EMBO JOURNAL (2015)

Article Cell Biology

Downregulation of E2F1 during ER stress is required to induce apoptosis

Vittoria Pagliarini et al.

JOURNAL OF CELL SCIENCE (2015)

Article Multidisciplinary Sciences

Ferroptosis as a p53-mediated activity during tumour suppression

Le Jiang et al.

NATURE (2015)

Editorial Material Cell Biology

TRP53 activates a global autophagy program to promote tumor suppression

Daniela Kenzelmann Broz et al.

AUTOPHAGY (2013)

Article Multidisciplinary Sciences

Mutational landscape and significance across 12 major cancer types

Cyriac Kandoth et al.

NATURE (2013)

Review Oncology

Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications

Marco Corazzari et al.

SEMINARS IN CANCER BIOLOGY (2013)

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.

Review Cell Biology

Reciprocal influence of the p53 and the hypoxic pathways

A. Sermeus et al.

CELL DEATH & DISEASE (2011)

Article Cell Biology

Autophagy regulation by p53

Maria Chiara Maiuri et al.

CURRENT OPINION IN CELL BIOLOGY (2010)

Article Multidisciplinary Sciences

Cytoplasmic functions of the tumour suppressor p53

Douglas R. Green et al.

NATURE (2009)

Article Cell Biology

Mutant p53 protein localized in the cytoplasm inhibits autophagy

Eugenia Morselli et al.

CELL CYCLE (2008)